Contineum Therapeutics | 8-K/A: Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Contineum Therapeutics | 8-K: Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Contineum Therapeutics | 8-K: Current report
Contineum Therapeutics | 8-K: Current report
Contineum Therapeutics | 8-K: Current report
Contineum Therapeutics | 8-K: Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Contineum Therapeutics | 8-K: Current report
Contineum Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Contineum Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Contineum Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
No Data
No Data